.05%Cyclosporine(Restasis)QID(Miebo).09%Cyclosporine(Cequa)Indicated forthe treatment ofthe signs &symptoms ofDED(M, V, T, X)Lifitegrast5%(Xiidra)Ocularburning17%(Restasis)30 daysupply is 60.2ml vials(Xiidra)65% of centralcorneas werecompletelyclear at 3months(Cequa)Installationsitereactions 8%(Vevye)Fre99.8% ofpatientsreported no ormildstinging/burning(Vevye)e!100%perfluorohexy-loctane(Miebo)2ml in a5ml bottle(Vevye).03mg ofvarenicline(Tyrvaya)1-3% of pts.reportedblurred visionand eyeredness(Miebo)SymptomImprovementin the first 30days(Vevye).1%cyclosporine(Vevye)Improvementin SchirmerScore at day28(Tyrvaya)Increase inSchirmer scoreof 10mm overvehicle in 6 mo(Restasis)Improvementin visualacuity as earlyas day 56(Cequa)95% of patientsexperienced noor mildinstallation sitepain (Cequa)Throatirritation13% ofpatients(Tyrvaya)Availablefor $79(Vevye)one monthsupply is 60.25ml vials(Cequa)Patients stayon treatmentlonger thenRestasis andXiidra(Cequa)Blurred Visionwas the mostcommon ocularadversereaction(Miebo)SymptomaticRelief in 2weeks in 2 outof 4 studies(Xiidra)The first andonly prescriptiondrop that directlytargets tearevaporationMoneyBackGuarantee(Vevye)Wait 30minutes toinstill contactlenses(Miebo)Relief frominflammationin the first 15days(Vevye)82% ofpatientsreportedsneezing(Tyrvaya)Reduces thesigns of dry eyeby week 12 insome patients(Xiidra)30-daysupply is two4.2ml bottles(Tyrvaya)Improvementin cornealstaining afterjust 14 days(Cequa)Calcineurininhibitorimmuno-suppressantopthalmicsolution (Cequa)When TYRVAYAhas not beenused for morethan 5 days, re-prime with 1spray into the air.05%Cyclosporine(Restasis)QID(Miebo).09%Cyclosporine(Cequa)Indicated forthe treatment ofthe signs &symptoms ofDED(M, V, T, X)Lifitegrast5%(Xiidra)Ocularburning17%(Restasis)30 daysupply is 60.2ml vials(Xiidra)65% of centralcorneas werecompletelyclear at 3months(Cequa)Installationsitereactions 8%(Vevye)Fre99.8% ofpatientsreported no ormildstinging/burning(Vevye)e!100%perfluorohexy-loctane(Miebo)2ml in a5ml bottle(Vevye).03mg ofvarenicline(Tyrvaya)1-3% of pts.reportedblurred visionand eyeredness(Miebo)SymptomImprovementin the first 30days(Vevye).1%cyclosporine(Vevye)Improvementin SchirmerScore at day28(Tyrvaya)Increase inSchirmer scoreof 10mm overvehicle in 6 mo(Restasis)Improvementin visualacuity as earlyas day 56(Cequa)95% of patientsexperienced noor mildinstallation sitepain (Cequa)Throatirritation13% ofpatients(Tyrvaya)Availablefor $79(Vevye)one monthsupply is 60.25ml vials(Cequa)Patients stayon treatmentlonger thenRestasis andXiidra(Cequa)Blurred Visionwas the mostcommon ocularadversereaction(Miebo)SymptomaticRelief in 2weeks in 2 outof 4 studies(Xiidra)The first andonly prescriptiondrop that directlytargets tearevaporationMoneyBackGuarantee(Vevye)Wait 30minutes toinstill contactlenses(Miebo)Relief frominflammationin the first 15days(Vevye)82% ofpatientsreportedsneezing(Tyrvaya)Reduces thesigns of dry eyeby week 12 insome patients(Xiidra)30-daysupply is two4.2ml bottles(Tyrvaya)Improvementin cornealstaining afterjust 14 days(Cequa)Calcineurininhibitorimmuno-suppressantopthalmicsolution (Cequa)When TYRVAYAhas not beenused for morethan 5 days, re-prime with 1spray into the air

Competitive Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
  1. .05% Cyclosporine (Restasis)
  2. QID (Miebo)
  3. .09% Cyclosporine (Cequa)
  4. Indicated for the treatment of the signs & symptoms of DED (M, V, T, X)
  5. Lifitegrast 5% (Xiidra)
  6. Ocular burning 17% (Restasis)
  7. 30 day supply is 60 .2ml vials (Xiidra)
  8. 65% of central corneas were completely clear at 3 months (Cequa)
  9. Installation site reactions 8% (Vevye)
  10. Fre99.8% of patients reported no or mild stinging/burning (Vevye)e!
  11. 100% perfluorohexy-loctane (Miebo)
  12. 2ml in a 5ml bottle (Vevye)
  13. .03mg of varenicline (Tyrvaya)
  14. 1-3% of pts. reported blurred vision and eye redness (Miebo)
  15. Symptom Improvement in the first 30 days (Vevye)
  16. .1% cyclosporine (Vevye)
  17. Improvement in Schirmer Score at day 28 (Tyrvaya)
  18. Increase in Schirmer score of 10mm over vehicle in 6 mo (Restasis)
  19. Improvement in visual acuity as early as day 56 (Cequa)
  20. 95% of patients experienced no or mild installation site pain (Cequa)
  21. Throat irritation 13% of patients (Tyrvaya)
  22. Available for $79 (Vevye)
  23. one month supply is 60 .25ml vials (Cequa)
  24. Patients stay on treatment longer then Restasis and Xiidra (Cequa)
  25. Blurred Vision was the most common ocular adverse reaction (Miebo)
  26. Symptomatic Relief in 2 weeks in 2 out of 4 studies (Xiidra)
  27. The first and only prescription drop that directly targets tear evaporation
  28. Money Back Guarantee (Vevye)
  29. Wait 30 minutes to instill contact lenses (Miebo)
  30. Relief from inflammation in the first 15 days (Vevye)
  31. 82% of patients reported sneezing (Tyrvaya)
  32. Reduces the signs of dry eye by week 12 in some patients (Xiidra)
  33. 30-day supply is two 4.2ml bottles (Tyrvaya)
  34. Improvement in corneal staining after just 14 days (Cequa)
  35. Calcineurin inhibitor immuno-suppressant opthalmic solution (Cequa)
  36. When TYRVAYA has not been used for more than 5 days, re-prime with 1 spray into the air